UniProt ID | ERF_HUMAN | |
---|---|---|
UniProt AC | P50548 | |
Protein Name | ETS domain-containing transcription factor ERF | |
Gene Name | ERF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 548 | |
Subcellular Localization | Nucleus. | |
Protein Description | Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment (By similarity). May be important for regulating trophoblast stem cell differentiation (By similarity).. | |
Protein Sequence | MKTPADTGFAFPDWAYKPESSPGSRQIQLWHFILELLRKEEYQGVIAWQGDYGEFVIKDPDEVARLWGVRKCKPQMNYDKLSRALRYYYNKRILHKTKGKRFTYKFNFNKLVLVNYPFIDVGLAGGAVPQSAPPVPSGGSHFRFPPSTPSEVLSPTEDPRSPPACSSSSSSLFSAVVARRLGRGSVSDCSDGTSELEEPLGEDPRARPPGPPDLGAFRGPPLARLPHDPGVFRVYPRPRGGPEPLSPFPVSPLAGPGSLLPPQLSPALPMTPTHLAYTPSPTLSPMYPSGGGGPSGSGGGSHFSFSPEDMKRYLQAHTQSVYNYHLSPRAFLHYPGLVVPQPQRPDKCPLPPMAPETPPVPSSASSSSSSSSSPFKFKLQPPPLGRRQRAAGEKAVAGADKSGGSAGGLAEGAGALAPPPPPPQIKVEPISEGESEEVEVTDISDEDEEDGEVFKTPRAPPAPPKPEPGEAPGASQCMPLKLRFKRRWSEDCRLEGGGGPAGGFEDEGEDKKVRGEGPGEAGGPLTPRRVSSDLQHATAQLSLEHRDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Ubiquitination | ------MKTPADTGF ------CCCCCCCCC | 64.32 | - | |
2 | Methylation | ------MKTPADTGF ------CCCCCCCCC | 64.32 | - | |
3 | Phosphorylation | -----MKTPADTGFA -----CCCCCCCCCC | 23.55 | 23401153 | |
7 | Phosphorylation | -MKTPADTGFAFPDW -CCCCCCCCCCCCCC | 35.98 | 23927012 | |
16 | Phosphorylation | FAFPDWAYKPESSPG CCCCCCCCCCCCCCC | 23.87 | 23927012 | |
17 | Ubiquitination | AFPDWAYKPESSPGS CCCCCCCCCCCCCCH | 34.26 | - | |
20 | Phosphorylation | DWAYKPESSPGSRQI CCCCCCCCCCCHHHH | 50.81 | 22167270 | |
21 | Phosphorylation | WAYKPESSPGSRQIQ CCCCCCCCCCHHHHH | 31.45 | 22167270 | |
24 | Phosphorylation | KPESSPGSRQIQLWH CCCCCCCHHHHHHHH | 25.13 | 22167270 | |
30 | Ubiquitination | GSRQIQLWHFILELL CHHHHHHHHHHHHHH | 2.83 | - | |
71 | Ubiquitination | ARLWGVRKCKPQMNY HHHHCCCCCCCCCCH | 44.17 | - | |
73 | Ubiquitination | LWGVRKCKPQMNYDK HHCCCCCCCCCCHHH | 41.12 | - | |
80 | Ubiquitination | KPQMNYDKLSRALRY CCCCCHHHHHHHHHH | 37.69 | - | |
105 | Ubiquitination | KGKRFTYKFNFNKLV CCCCEEEEECCCEEE | 30.67 | 21890473 | |
105 | Ubiquitination | KGKRFTYKFNFNKLV CCCCEEEEECCCEEE | 30.67 | 21890473 | |
131 | Phosphorylation | AGGAVPQSAPPVPSG CCCCCCCCCCCCCCC | 36.35 | 30183078 | |
137 | Phosphorylation | QSAPPVPSGGSHFRF CCCCCCCCCCCCCCC | 56.89 | 29514088 | |
140 | Phosphorylation | PPVPSGGSHFRFPPS CCCCCCCCCCCCCCC | 23.99 | 29514088 | |
147 | Phosphorylation | SHFRFPPSTPSEVLS CCCCCCCCCHHHCCC | 53.86 | 26503892 | |
148 | Phosphorylation | HFRFPPSTPSEVLSP CCCCCCCCHHHCCCC | 36.29 | 30266825 | |
150 | Phosphorylation | RFPPSTPSEVLSPTE CCCCCCHHHCCCCCC | 40.19 | 29255136 | |
154 | Phosphorylation | STPSEVLSPTEDPRS CCHHHCCCCCCCCCC | 34.64 | 26503892 | |
156 | Phosphorylation | PSEVLSPTEDPRSPP HHHCCCCCCCCCCCC | 50.04 | 29255136 | |
161 | Phosphorylation | SPTEDPRSPPACSSS CCCCCCCCCCCCCCC | 40.39 | 27794612 | |
166 | Phosphorylation | PRSPPACSSSSSSLF CCCCCCCCCCHHHHH | 35.05 | 23663014 | |
167 | Phosphorylation | RSPPACSSSSSSLFS CCCCCCCCCHHHHHH | 33.84 | 23663014 | |
168 | Phosphorylation | SPPACSSSSSSLFSA CCCCCCCCHHHHHHH | 20.25 | 23663014 | |
169 | Phosphorylation | PPACSSSSSSLFSAV CCCCCCCHHHHHHHH | 26.37 | 23663014 | |
170 | Phosphorylation | PACSSSSSSLFSAVV CCCCCCHHHHHHHHH | 32.77 | 23663014 | |
171 | Phosphorylation | ACSSSSSSLFSAVVA CCCCCHHHHHHHHHH | 35.07 | 23663014 | |
174 | Phosphorylation | SSSSSLFSAVVARRL CCHHHHHHHHHHHHH | 26.00 | 23663014 | |
183 | Methylation | VVARRLGRGSVSDCS HHHHHHCCCCCCCCC | 38.51 | - | |
185 | Phosphorylation | ARRLGRGSVSDCSDG HHHHCCCCCCCCCCC | 19.65 | 23401153 | |
187 | Phosphorylation | RLGRGSVSDCSDGTS HHCCCCCCCCCCCCC | 34.30 | 29255136 | |
190 | Phosphorylation | RGSVSDCSDGTSELE CCCCCCCCCCCCCCC | 44.03 | 23927012 | |
193 | Phosphorylation | VSDCSDGTSELEEPL CCCCCCCCCCCCCCC | 24.82 | 23927012 | |
194 | Phosphorylation | SDCSDGTSELEEPLG CCCCCCCCCCCCCCC | 45.79 | 23927012 | |
218 | Methylation | PPDLGAFRGPPLARL CCCCCCCCCCCCCCC | 57.06 | - | |
224 | Methylation | FRGPPLARLPHDPGV CCCCCCCCCCCCCCC | 57.33 | - | |
233 | Methylation | PHDPGVFRVYPRPRG CCCCCCEEEECCCCC | 25.34 | - | |
246 | Phosphorylation | RGGPEPLSPFPVSPL CCCCCCCCCCCCCCC | 34.90 | 22817900 | |
251 | Phosphorylation | PLSPFPVSPLAGPGS CCCCCCCCCCCCCCC | 17.90 | 22817900 | |
313 | Phosphorylation | SPEDMKRYLQAHTQS CHHHHHHHHHHHHHH | 9.54 | 23403867 | |
318 | Phosphorylation | KRYLQAHTQSVYNYH HHHHHHHHHHHHHHC | 26.09 | 28152594 | |
319 | Acetylation | RYLQAHTQSVYNYHL HHHHHHHHHHHHHCC | 22.49 | - | |
320 | Phosphorylation | YLQAHTQSVYNYHLS HHHHHHHHHHHHCCC | 27.94 | 28152594 | |
322 | Phosphorylation | QAHTQSVYNYHLSPR HHHHHHHHHHCCCCC | 18.43 | 23403867 | |
324 | Phosphorylation | HTQSVYNYHLSPRAF HHHHHHHHCCCCCCC | 6.10 | 23927012 | |
327 | Phosphorylation | SVYNYHLSPRAFLHY HHHHHCCCCCCCCCC | 10.06 | 23401153 | |
329 | Methylation | YNYHLSPRAFLHYPG HHHCCCCCCCCCCCC | 34.30 | - | |
334 | Phosphorylation | SPRAFLHYPGLVVPQ CCCCCCCCCCCCCCC | 10.92 | 27642862 | |
357 | Phosphorylation | LPPMAPETPPVPSSA CCCCCCCCCCCCCCC | 31.65 | 25850435 | |
362 | Phosphorylation | PETPPVPSSASSSSS CCCCCCCCCCCCCCC | 38.48 | 25850435 | |
363 | Phosphorylation | ETPPVPSSASSSSSS CCCCCCCCCCCCCCC | 26.54 | 27251275 | |
365 | Phosphorylation | PPVPSSASSSSSSSS CCCCCCCCCCCCCCC | 32.47 | 27251275 | |
366 | Phosphorylation | PVPSSASSSSSSSSS CCCCCCCCCCCCCCC | 33.68 | 27251275 | |
367 | Phosphorylation | VPSSASSSSSSSSSP CCCCCCCCCCCCCCC | 31.57 | 25850435 | |
368 | Phosphorylation | PSSASSSSSSSSSPF CCCCCCCCCCCCCCC | 35.87 | 25850435 | |
369 | Phosphorylation | SSASSSSSSSSSPFK CCCCCCCCCCCCCCC | 35.87 | 25850435 | |
370 | Phosphorylation | SASSSSSSSSSPFKF CCCCCCCCCCCCCCE | 35.87 | 25850435 | |
371 | Phosphorylation | ASSSSSSSSSPFKFK CCCCCCCCCCCCCEE | 36.46 | 27251275 | |
372 | Phosphorylation | SSSSSSSSSPFKFKL CCCCCCCCCCCCEEC | 43.93 | 27251275 | |
373 | Phosphorylation | SSSSSSSSPFKFKLQ CCCCCCCCCCCEECC | 35.98 | 25850435 | |
376 | Methylation | SSSSSPFKFKLQPPP CCCCCCCCEECCCCC | 45.00 | - | |
378 | Sumoylation | SSSPFKFKLQPPPLG CCCCCCEECCCCCCC | 46.96 | - | |
378 | Sumoylation | SSSPFKFKLQPPPLG CCCCCCEECCCCCCC | 46.96 | - | |
394 | Acetylation | RQRAAGEKAVAGADK HHHHCHHHCCCCCCC | 47.44 | 23749302 | |
402 | Phosphorylation | AVAGADKSGGSAGGL CCCCCCCCCCCCCHH | 49.27 | 28555341 | |
405 | Phosphorylation | GADKSGGSAGGLAEG CCCCCCCCCCHHHCC | 27.54 | 28387310 | |
431 | Phosphorylation | QIKVEPISEGESEEV CCEEEECCCCCCCEE | 50.71 | 27422710 | |
435 | Phosphorylation | EPISEGESEEVEVTD EECCCCCCCEEEEEE | 50.33 | 27422710 | |
441 | Phosphorylation | ESEEVEVTDISDEDE CCCEEEEEECCCCCC | 17.70 | 25072903 | |
444 | Phosphorylation | EVEVTDISDEDEEDG EEEEEECCCCCCCCC | 37.44 | 25072903 | |
456 | Phosphorylation | EDGEVFKTPRAPPAP CCCCEECCCCCCCCC | 13.42 | 21406692 | |
465 | Sumoylation | RAPPAPPKPEPGEAP CCCCCCCCCCCCCCC | 62.04 | - | |
465 | Sumoylation | RAPPAPPKPEPGEAP CCCCCCCCCCCCCCC | 62.04 | 28112733 | |
475 | Phosphorylation | PGEAPGASQCMPLKL CCCCCCCCCCCCCEE | 29.81 | 28555341 | |
481 | Sumoylation | ASQCMPLKLRFKRRW CCCCCCCEECEEECC | 31.57 | 28112733 | |
489 | Phosphorylation | LRFKRRWSEDCRLEG ECEEECCCCCCCCCC | 23.03 | 23401153 | |
512 | Sumoylation | EDEGEDKKVRGEGPG CCCCCCCCCCCCCCC | 49.87 | 28112733 | |
512 | Sumoylation | EDEGEDKKVRGEGPG CCCCCCCCCCCCCCC | 49.87 | - | |
526 | Phosphorylation | GEAGGPLTPRRVSSD CCCCCCCCCCCCCHH | 20.20 | 19664994 | |
531 | Phosphorylation | PLTPRRVSSDLQHAT CCCCCCCCHHHHHHH | 19.14 | 29255136 | |
532 | Phosphorylation | LTPRRVSSDLQHATA CCCCCCCHHHHHHHH | 39.21 | 29255136 | |
538 | Phosphorylation | SSDLQHATAQLSLEH CHHHHHHHHHHHHHC | 16.89 | 23927012 | |
542 | Phosphorylation | QHATAQLSLEHRDS- HHHHHHHHHHCCCC- | 21.45 | 23927012 | |
548 | Phosphorylation | LSLEHRDS------- HHHHCCCC------- | 41.92 | 23927012 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
161 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
246 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
251 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
526 | T | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
526 | T | Phosphorylation |
| 7588608 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SPOP_HUMAN | SPOP | physical | 26344095 | |
MARF1_HUMAN | KIAA0430 | physical | 27173435 | |
PAN2_HUMAN | PAN2 | physical | 27173435 | |
NISCH_HUMAN | NISCH | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
600775 | Craniosynostosis 4 (CRS4) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-444 ANDTHR-526, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; THR-7; TYR-16;SER-20; SER-21; THR-148; SER-171; SER-185; SER-187; SER-190; SER-327;SER-431; SER-435; THR-441; SER-444; THR-526; SER-531 AND SER-548, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-185; SER-187;SER-190 AND SER-531, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-526, AND MASSSPECTROMETRY. | |
"ERF: an ETS domain protein with strong transcriptional repressoractivity, can suppress ets-associated tumorigenesis and is regulatedby phosphorylation during cell cycle and mitogenic stimulation."; Sgouras D.N., Athanasiou M.A., Beal G.J. Jr., Fisher R.J., Blair D.G.,Mavrothalassitis G.J.; EMBO J. 14:4781-4793(1995). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-526, ANDMUTAGENESIS OF THR-526. |